Azenta US, INC.:1334447 [23-004118]

Ended Purchase Order Awarded Last action

Contract number
75N95023P00273
Awardee
Awarding agency
Obligated
$30,305

Award facts

Opportunity
Contract value 15% obligated
  • $30,305.00 Current, with exercised options
  • $203,141.00 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Indianapolis, IN 46241, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $30,305

About this award

The National Institute on Drug Abuse awarded a purchase order to Azenta US Inc. (doing business as Brooks Life Sciences Inc.) valued at $203,141 on May 18, 2023, with ultimate completion on February 10, 2028. No set-aside was used. Work is performed in Indianapolis, Indiana. The order is firm fixed price. The solicitation was posted April 25, 2023 and closed May 5, 2023.

Quick answers

Who was awarded contract 75N95023P00273?

75N95023P00273 was awarded to Azenta US Inc. by National Institute on Drug Abuse (National Institutes of Health) on May 18, 2023.

How much is contract 75N95023P00273 worth?

The government has obligated $30,305 on 75N95023P00273. Its potential value, with all options, is $203,141.

Was contract 75N95023P00273 competed?

The extent of competition for 75N95023P00273 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award